Browsing Tag
ORICISION
1 post
Ipsen secures global licensing option for Origami’s selective protein degrader platform
Ipsen has signed a global option deal with Origami Therapeutics for a rare CNS protein degrader. Find out what this signals for neuro drug strategy.